annual CFO:
-$158.56M-$17.35M(-12.28%)Summary
- As of today (September 17, 2025), NAMS annual cash flow from operations is -$158.56 million, with the most recent change of -$17.35 million (-12.28%) on December 31, 2024.
- During the last 3 years, NAMS annual CFO has fallen by -$129.05 million (-437.29%).
- NAMS annual CFO is now -1586.77% below its all-time high of $10.66 million, reached on December 31, 2022.
Performance
NAMS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$37.67M-$1.20M(-3.30%)Summary
- As of today (September 17, 2025), NAMS quarterly cash flow from operations is -$37.67 million, with the most recent change of -$1.20 million (-3.30%) on June 30, 2025.
- Over the past year, NAMS quarterly CFO has increased by +$16.31 million (+30.21%).
- NAMS quarterly CFO is now -6473.03% below its all-time high of $591.10 thousand, reached on December 31, 2021.
Performance
NAMS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$124.12M+$16.31M(+11.61%)Summary
- As of today (September 17, 2025), NAMS TTM cash flow from operations is -$124.12 million, with the most recent change of +$16.31 million (+11.61%) on June 30, 2025.
- Over the past year, NAMS TTM CFO has dropped by -$15.54 million (-14.31%).
- NAMS TTM CFO is now -96044.07% below its all-time high of -$129.10 thousand, reached on June 30, 2022.
Performance
NAMS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NAMS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.3% | +30.2% | -14.3% |
| 3 y3 years | -437.3% | -10000.0% | -10000.0% |
| 5 y5 years | -2059.4% | - | - |
NAMS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1586.8% | at low | <-9999.0% | +31.0% | <-9999.0% | +21.7% |
| 5 y | 5-year | -1586.8% | at low | -6473.0% | +31.0% | <-9999.0% | +21.7% |
| alltime | all time | -1586.8% | at low | -6473.0% | +31.0% | <-9999.0% | +21.7% |
NAMS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$37.67M(+3.3%) | -$124.12M(-11.6%) |
| Mar 2025 | - | -$36.47M(-2.7%) | -$140.43M(-11.4%) |
| Dec 2024 | -$158.56M(+12.3%) | -$37.48M(+199.8%) | -$158.56M(+31.0%) |
| Sep 2024 | - | -$12.50M(-76.8%) | -$121.08M(+11.5%) |
| Jun 2024 | - | -$53.98M(-1.1%) | -$108.58M(+98.9%) |
| Mar 2024 | - | -$54.60M(+71.4%) | -$54.60M(+69.2%) |
| Dec 2023 | -$141.22M(-1424.1%) | - | - |
| Mar 2023 | - | -$31.86M | -$32.28M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $10.66M(-136.1%) | - | - |
| Sep 2022 | - | -$239.90K(+39.0%) | -$215.10K(+66.6%) |
| Jun 2022 | - | -$172.60K(-56.2%) | -$129.10K(-60.8%) |
| Mar 2022 | - | -$393.70K(-166.6%) | -$329.60K(+138.2%) |
| Dec 2021 | -$29.51M(+301.9%) | $591.10K(-484.1%) | -$138.40K(-81.0%) |
| Sep 2021 | - | -$153.90K(-58.8%) | -$729.50K(+26.7%) |
| Jun 2021 | - | -$373.10K(+84.2%) | -$575.60K(+184.2%) |
| Mar 2021 | - | -$202.50K | -$202.50K |
| Dec 2020 | -$7.34M | - | - |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual cash flow from operations?
- What is the all time high annual CFO for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual CFO year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly cash flow from operations?
- What is the all time high quarterly CFO for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly CFO year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM cash flow from operations?
- What is the all time high TTM CFO for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM CFO year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual cash flow from operations?
The current annual CFO of NAMS is -$158.56M
What is the all time high annual CFO for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual cash flow from operations is $10.66M
What is NewAmsterdam Pharma Company N.V. annual CFO year-on-year change?
Over the past year, NAMS annual cash flow from operations has changed by -$17.35M (-12.28%)
What is NewAmsterdam Pharma Company N.V. quarterly cash flow from operations?
The current quarterly CFO of NAMS is -$37.67M
What is the all time high quarterly CFO for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly cash flow from operations is $591.10K
What is NewAmsterdam Pharma Company N.V. quarterly CFO year-on-year change?
Over the past year, NAMS quarterly cash flow from operations has changed by +$16.31M (+30.21%)
What is NewAmsterdam Pharma Company N.V. TTM cash flow from operations?
The current TTM CFO of NAMS is -$124.12M
What is the all time high TTM CFO for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM cash flow from operations is -$129.10K
What is NewAmsterdam Pharma Company N.V. TTM CFO year-on-year change?
Over the past year, NAMS TTM cash flow from operations has changed by -$15.54M (-14.31%)